Main clinical characteristics of the study cohort (n = 682 patients)
| . | Median (IQR) . |
|---|---|
| Age at diagnosis, y | 74 (66-80) |
| Female sex, % | 73.3 |
| Hemoglobin, g/dL | 9.2 (8.1-10.3) |
| WBC count, × 109/L | 4.1 (3-5.5) |
| Neutrophils, × 109/L | 2.0 (1.3-3.1) |
| Platelet count, × 109/L | 249 (169-347) |
| Bone marrow blasts, % | 2 (1-3.5) |
| Cytogenetics, n (%) | |
| Isolated del(q) | 568 (83.3) |
| +1 additional abnormality | 114 (16.7) |
| IPSS-R, n (%) | |
| Very low | 184 (38.5) |
| Low | 243 (50.8) |
| Intermediate | 51 (10.7) |
| . | Median (IQR) . |
|---|---|
| Age at diagnosis, y | 74 (66-80) |
| Female sex, % | 73.3 |
| Hemoglobin, g/dL | 9.2 (8.1-10.3) |
| WBC count, × 109/L | 4.1 (3-5.5) |
| Neutrophils, × 109/L | 2.0 (1.3-3.1) |
| Platelet count, × 109/L | 249 (169-347) |
| Bone marrow blasts, % | 2 (1-3.5) |
| Cytogenetics, n (%) | |
| Isolated del(q) | 568 (83.3) |
| +1 additional abnormality | 114 (16.7) |
| IPSS-R, n (%) | |
| Very low | 184 (38.5) |
| Low | 243 (50.8) |
| Intermediate | 51 (10.7) |
WBC, white blood cell.